MMP13 and neoplasm: A recent study suggests that MC-LR activate the PI3K/AKT pathway, which leads to increased matrix metalloproteinase-13 (MMP-13) expression, resulting in enhanced migration and invasion of Duke's Lymphoma Disease 1 (DLD-1) and Human Tumor 29 (HT-29) cells.